1. Modulation of a L-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors;J Basic Clin Physiol Pharmacol,2016
2. GPR55 – a putative “type 3” cannabinoid receptor in inflammation;J Basic Clin Physiol Pharmacol,2016
3. A collaboration investigating endocannabinoid signalling in brain and bone;J Basic Clin Physiol Pharmacol,2016
4. Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease;J Basic Clin Physiol Pharmacol,2016
5. A collaboration investigating endocannabinoid signalling in brain and bone;J Basic Clin Physiol Pharmacol,2016